Biotech Updates

Undue Delays in the EU Approval of Safe GM Products

May 11, 2012

EuropaBio has published a document listing the status of GM applications in the decision making phase of the EU approval process. The approval process in the EU is considered one of the strictest. After an extensive scientific risk assessment, the European Food Safety Authority (EFSA) will endorse a particular decision to the European Commission for final authorization. This decision making phase should take three months in the hands of the EU Commission and the Member States to reach the Standing Committee for a decision. After which, if there is a need to appeal, the commission has to submit the approval dossier to the Appeal Committee within two months.

EuropaBio disclosed the status of European Approval Process which indicate that there has been enormous delays and does not conform with the approval timeline.

See the article at